Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Octeau

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Oncology|November 15, 2021
Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum AgentsEmad Matanes, Vanessa M López-Ozuna, David Octeau, et al.
Gynecologic Oncology Reports|December 24, 2019
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsyDavid Octeau, Jeremie Abitbol, Zainab Amajoud, et al.
Molecular Cancer Research : MCR|September 19, 2019
Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant ChemotherapyDavid Octeau, Roy Kessous, Kathleen Klein, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Frontiers in Oncology|November 15, 2021
Inhibition of Poly ADP-Ribose Glycohydrolase Sensitizes Ovarian Cancer Cells to Poly ADP-Ribose Polymerase Inhibitors and Platinum AgentsEmad Matanes, Vanessa M López-Ozuna, David Octeau, et al.
Gynecologic Oncology Reports|December 24, 2019
Targeted sequencing of histologically defined serous endometrial cancer reflects prognosis and correlates with preoperative biopsyDavid Octeau, Jeremie Abitbol, Zainab Amajoud, et al.
Molecular Cancer Research : MCR|September 19, 2019
Outcome-Related Differences in Gene Expression Profiles of High-Grade Serous Ovarian Cancers Following Neoadjuvant ChemotherapyDavid Octeau, Roy Kessous, Kathleen Klein, et al.
Pageof 2